Aspirin in primary prevention of cardiovascular disease in the elderly

European Heart Journal - Cardiovascular Pharmacotherapy

24 September 2019

Organised by:

Read full article

Contributors

Mattia Galli

Mattia Galli

Author

Felicita Andreotti

Felicita Andreotti

Author

IRCCS Foundation Agostino Gemelli University Hospital Rome , Italy

Domenico D’Amario

Domenico D’Amario

Author

Rocco Vergallo

Rocco Vergallo

Author

Rocco A Montone

Rocco A Montone

Author

IRCCS Foundation Agostino Gemelli University Hospital Rome , Italy

Italo Porto

Italo Porto

Author

Filippo Crea

Filippo Crea

Author

You may be interested in

Webinar

Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum

6 July 2023

Congress Presentation

Managing dyslipidemia in the elderly: efficacy and safety of bempedoic acid in very high-risk patients

4 April 2025

Congress Presentation

Underutilization of guideline-recommended therapy in patients 80 years and older with peripheral artery diseases

25 August 2023

Congress Presentation

Aspirin and long-Term risk of heart failure in patients with high atherosclerotic risk

20 May 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources